Mamento, Hanan S.
HRN: 11-46-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2023
CEFUROXIME 1.5GM (VIAL)
09/13/2023
09/20/2023
IVT
1.5 Gms
Now Then Q 8 Hrs
S/P LTCS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes